Plus   Neg

Centrica 4-month Trading Largely Inline With View; Maintains FY Guidance

Centrica plc (CNA.L) on Monday said its operational performance in the first four months of 2019 has been largely in line with expectations, despite challenging trading environment. The company also maintained full year guidance on operating cash flow and net debt.

In its trading statement, the company noted that its trading environment in the four months has been challenging due to a specific set of external factors. These included the expected negative impact from the UK default tariff cap, including the one-off 70 million pounds impact in the first quarter, warmer than normal weather and falling UK natural gas prices.

The company also experienced extensions to outages at the non-operated Dungeness B and Hunterston B nuclear power stations.

The company said these factors are temporary in nature, but will impact financial performance in the first half of 2019 and have also put some further pressure on the outlook for the full year.

However, Centrica is maintaining its full-year guidance on operating cash flow and net debt with cost efficiency delivery expected to accelerate in the second half and a continued focus on capital discipline.

Centrica continues to expect to achieve adjusted operating cash flow in the 1.8 billion pounds to 2 billion pounds range, in-year efficiency delivery of 250 million pounds, like-for-like headcount reduction of 1,500-2,000, and net debt within the 3 billion pounds to 3.5 billion pounds range, among others.

Centrica is due to release its 2019 Interim Results on July 30.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration or FDA announced on its website that pharma major Pfizer, Inc. issued recall of two lots of tablets meant to treat acute migraine in adults for concerns over bacteria infection. The pharma company is recalling two lots of Relpax (eletriptan hydrobromide) 40 mg tablets for potential presence of Genus Pseudomonas and Burkholderia bacteria. Cosmetics company Revlon Inc. (REV) is reportedly considering a potential sale of parts or all of its business. According to Bloomberg, Revlon has retained financial advisers from Goldman Sachs Group Inc. to explore strategic alternatives. No deal has been reached yet, but Revlon is exploring all... China's Lenovo Group Ltd. warned it may have to raise prices of its products if the U.S. moves ahead with the decision to impose additional tariffs on Chinese goods, according to a report by Reuters. The warning by Lenovo, the world's largest PC maker, comes amid the escalating trade war between the U.S. and China that has raised concerns about the global economic outlook.
Follow RTT